Skip to main content

Table 1 Parameters before TAA surgery (baseline) in each group analysed (mean ± SD)

From: Fibrinogen concentrate administration attributes to significant reductions of blood loss and transfusion requirements in thoracic aneurysm repair

  Only FFP (n = 24) Fibrinogen concentrate (n = 25)
Hb (g/dL) 13.7 ± 2.7 14.2 ± 2.9
Platelet (× 1000/μL) 178 ± 57 153 ± 38
PT (sec.) 11.2 ± 1.3 11.4 ± 1.0
APTT (sec.) 33.7 ± 2.6 34.1 ± 2.8
Fibrinogen (mg/dL)
Baseline 275 ± 66 268 ± 57
End of CPB 116 ± 33 108 ± 39
End of operation 141 ± 36 252 ± 46*
  1. The fibrinogen levels at the end of CPB and of surgery in each group are also indicated.
  2. TAA: thoracic aortic aneurysm; CPB: cardiopulmonary bypass; Hb: hemoglobin; PT: prothrombin time; APTT: activated partial thromboplastin time; *P < 0.02.